Scienture Holdings, Inc. (SCNX)
Official siteHEALTHCARE • PHARMACEUTICAL RETAILERS • NASDAQ
Market Cap: $4.76M
Last updated: Nov 17, 2026 at 11:04 AM ET
Scienture Holdings, Inc. (SCNX) Competitors
The companies most similar to Scienture Holdings are CNS Pharmaceuticals (CNSP), Neurosense Therapeutics (NRSN) and Senti Biosciences (SNTI). By market cap, Scienture Holdings ranks 7th of the 13 companies on this page; Ensysce Biosciences (ENSC) is the largest at $8.14M.
Peer Comparison
SCNX's ROIC of -56.2% is above the peer median of -260.6%, and its revenue growth of 449.1% is above the median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Scienture Holdings (SCNX) | $4.76M | N/A | 3.2x | 0.0% | -56.2% | 449.1% | 0.00% |
| CNS Pharmaceuticals Inc (CNSP) | $4.22M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Neurosense Therapeutics Ltd (NRSN) | $3.21M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Senti Biosciences Inc (SNTI) | $5.38M | N/A | 57.2x | 0.0% | 1039.8% | -100.0% | 0.00% |
| Exicure Inc (XCUR) | $7.07M | N/A | N/A | 0.0% | N/A | 928.0% | 0.00% |
| Skye Bioscience, Inc. Common Stock (SKYE) | $4.83M | N/A | N/A | 0.0% | -3685.3% | 0.0% | 0.00% |
| Intelligent Bio Solutions Inc. (INBS) | $5.84M | N/A | 1.0x | -269.3% | N/A | 25.2% | 0.00% |
| NuCana PLC (NCNA) | $3.88M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Soligenix Inc. (SNGX) | $7.50M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| SeaStar Medical Holding Corporation (ICU) | $4.46M | N/A | 1.7x | 0.0% | N/A | 82.0% | 0.00% |
| Ensysce Biosciences Inc (ENSC) | $8.14M | N/A | 1.2x | -280.5% | -260.6% | -15.1% | 0.00% |
| Creative Medical Technology Holdings Inc (CELZ) | $4.01M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Curis Inc (CRIS) | $2.97M | N/A | 1.6x | 0.0% | N/A | -66.0% | 0.00% |
| Peer median | $4.64M | N/A | 1.6x | 0.0% | -260.6% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Scienture Holdings, ranked by how closely their business, size, sector and industry match. The largest group, 11 of the 12, is in Biotechnology; the other one is in Medical Devices.
| Company | About | Peers |
|---|---|---|
| CNS Pharmaceuticals Inc (CNSP)Biotechnology | CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central... | CNSP competitors |
| Neurosense Therapeutics Ltd (NRSN)Biotechnology | Neurosense Therapeutics Ltd (NRSN) is a clinical-stage biotechnology firm dedicated to innovating treatments for neurodegenerative diseases... | |
| Senti Biosciences Inc (SNTI)Biotechnology | Senti Biosciences Inc (SNTI) is a leading biotechnology firm specializing in synthetic biology... | SNTI competitors |
| Exicure Inc (XCUR)Biotechnology | Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases... | XCUR competitors |
| Skye Bioscience, Inc. Common Stock (SKYE)Biotechnology | Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops... | SKYE competitors |
| Intelligent Bio Solutions Inc. (INBS)Medical Devices | Intelligent Bio Solutions Inc. (INBS) is a pioneering biotechnology company focused on delivering cutting-edge diagnostic solutions and biomarker-driven... | INBS competitors |
| NuCana PLC (NCNA)Biotechnology | NuCana plc, a clinical-stage biopharmaceutical company, is dedicated to the development of products for the treatment of cancer. | NCNA competitors |
| Soligenix Inc. (SNGX)Biotechnology | Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States. | SNGX competitors |
| SeaStar Medical Holding Corporation (ICU)Biotechnology | SeaStar Medical Holding Corporation (ICU) is a forward-looking biotechnology company dedicated to innovating treatment solutions for chronic kidney disease via... | ICU competitors |
| Ensysce Biosciences Inc (ENSC)Biotechnology | Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs. | ENSC competitors |
| Creative Medical Technology Holdings Inc (CELZ)Biotechnology | Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics... | CELZ competitors |
| Curis Inc (CRIS)Biotechnology | Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. | CRIS competitors |
Frequently Asked Questions About SCNX
Who are Scienture Holdings' main competitors?
The companies most similar to Scienture Holdings include CNS Pharmaceuticals (CNSP), Neurosense Therapeutics (NRSN), Senti Biosciences (SNTI), Exicure (XCUR) and Skye Bioscience, Inc. Common Stock (SKYE), listed from the closest match.
Who is Scienture Holdings' biggest competitor?
Ensysce Biosciences (ENSC) is the largest of the similar companies at $8.14M; CNS Pharmaceuticals (CNSP) is the closest match by business profile, size, sector and industry.
How does SCNX stock compare with its competitors?
SCNX's P/S is 3.2x against a peer median of 1.6x; its net margin is 0.0% against a peer median of 0.0%.
Which of Scienture Holdings' competitors pays a higher dividend?
Scienture Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Scienture Holdings bigger than its competitors?
No. Scienture Holdings is 7th by market cap among the 13 companies on this page; the largest is Ensysce Biosciences (ENSC) at $8.14M.
SCNX pages: Overview, Earnings, Forecast, Financials, Competitors